439 related articles for article (PubMed ID: 27362313)
1. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
2. CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition.
Han JL; Zimmerer JM; Zeng Q; Chaudhari SR; Hart M; Satoskar AA; Abdel-Rasoul M; Breuer CK; Bumgardner GL
Transplantation; 2024 Mar; 108(3):679-692. PubMed ID: 37872660
[TBL] [Abstract][Full Text] [Related]
3. Antibody-suppressor CD8+ T Cells Require CXCR5.
Zimmerer JM; Ringwald BA; Elzein SM; Avila CL; Warren RT; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2019 Sep; 103(9):1809-1820. PubMed ID: 30830040
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.
Han JL; Zimmerer JM; Zeng Q; Chaudhari S; Satoskar A; Abdel-Rasoul M; Uwase H; Breuer CK; Bumgardner GL
J Immunol; 2024 May; 212(9):1504-1518. PubMed ID: 38517294
[TBL] [Abstract][Full Text] [Related]
5. Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.
Zimmerer JM; Pham TA; Wright CL; Tobin KJ; Sanghavi PB; Elzein SM; Sanders VM; Bumgardner GL
Am J Transplant; 2014 Feb; 14(2):295-304. PubMed ID: 24472191
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
[TBL] [Abstract][Full Text] [Related]
8. Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials.
Glover TE; Watson CJ; Gibbs P; Bradley JA; Ntzani EE; Kosmoliaptsis V
Transplantation; 2016 Mar; 100(3):621-9. PubMed ID: 26636736
[TBL] [Abstract][Full Text] [Related]
9. Antibody-suppressor CXCR5
Zimmerer JM; Han JL; Peterson CM; Zeng Q; Ringwald BA; Cassol C; Chaudhari S; Hart M; Hemminger J; Satoskar A; Abdel-Rasoul M; Wang JJ; Warren RT; Zhang ZJ; Breuer CK; Bumgardner GL
Am J Transplant; 2022 Jun; 22(6):1550-1563. PubMed ID: 35114045
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.
Zimmerer JM; Pham TA; Sanders VM; Bumgardner GL
J Immunol; 2010 Dec; 185(12):7285-92. PubMed ID: 21084663
[TBL] [Abstract][Full Text] [Related]
11. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.
Merino D; San Segundo D; Medina JM; Rodrigo E; Asensio E; Irure J; Fernández-Fresnedo G; Arias MA; López-Hoyos M
Immunology; 2016 Jun; 148(2):206-15. PubMed ID: 26931075
[TBL] [Abstract][Full Text] [Related]
12. Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.
Zimmerer JM; Liu XL; Blaszczak A; Avila CL; Pham TA; Warren RT; Bumgardner GL
J Immunol; 2018 Dec; 201(12):3731-3740. PubMed ID: 30397035
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
Gareau AJ; Nashan B; Hirsch GM; Lee TD
J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675
[TBL] [Abstract][Full Text] [Related]
14. Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.
Zimmerer JM; Horne PH; Fisher MG; Pham TA; Lunsford KE; Ringwald BA; Avila CL; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1907-15. PubMed ID: 27379551
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Jayashankar K; Garcia SF; Abdel-Rasoul M; van Rooijen N; Bumgardner GL
Cell Transplant; 2013; 22(7):1157-69. PubMed ID: 23069206
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis.
Montero N; Quero M; Melilli E; Pérez-Sáez MJ; Redondo-Pachón D; Bestard O; Crespo M; Cruzado JM; Pascual J
Transplantation; 2019 Oct; 103(10):2031-2056. PubMed ID: 31343574
[TBL] [Abstract][Full Text] [Related]
17. Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Kubo K; Kawato Y; Nakamura K; Nakajima Y; Nakagawa TY; Hanaoka K; Oshima S; Fukahori H; Inami M; Morokata T; Higashi Y
Eur J Pharmacol; 2018 Nov; 838():145-152. PubMed ID: 30196110
[TBL] [Abstract][Full Text] [Related]
18. Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zeng J; Zhong Q; Feng X; Li L; Feng S; Fan Y; Song T; Huang Z; Wang X; Lin T
Front Immunol; 2021; 12():663602. PubMed ID: 34539621
[TBL] [Abstract][Full Text] [Related]
19. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
[TBL] [Abstract][Full Text] [Related]
20. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
Bumgardner GL; Gao D; Li J; Baskin JH; Heininger M; Orosz CG
Transplantation; 2000 Dec; 70(12):1771-80. PubMed ID: 11152110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
